... infarction Drug-eluting stent High bleeding risk Percutaneous coronary intervention The introduction of drug-eluting stents (DESs) revolutionized percutaneous coronary intervention (PCI) by significantly reducing rates of restenosis compared to bare-metal stents. The availability of DES allowed...

...Per Mølstad; Jan Erik Nordrehaug; Terje Steigen; Lasse Melvaer Giil; Tom Wilsgaard; Rune Wiseth; Kaare H. Bønaa Background: The NORSTENT trial randomized 9,013 patients to percutaneous coronary intervention (PCI) with a drug-eluting stent (DES) or bare-metal stent (BMS) with 5-year follow-up...

...Junhui Liu; Xiao-Zhen Zhuo; Weimin Liu; Zhaofei Wan; Xinhong Wang; Weiping Zhang; Shanshan Gao; Zuyi Yuan; Yue Wu Objective: The systematic pro-inflammatory responses after percutaneous coronary intervention with drug-eluting stents (DES) remain poorly defined. Therefore, we compared the systematic...

.... The objective was to assess the predictive value of SUA levels on mortality in ACS patients with CKD after drug-eluting stent (DES) implantation. Methods: We retrospectively assessed ACS patients with CKD who underwent successful DES implantation between January 2007 and December 2009. Patients were followed up...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Angioplasty Bifurcation lesions Drug-eluting stent Death was defined as any postprocedure death and was considered to be of cardiac origin unless there was documentation...

...Shuai Zheng; Zhe Zheng; Jianfeng Hou; Shengshou Hu Objective: The clinical outcomes for unprotected left main coronary artery (LMCA) between coronary artery bypass grafting (CABG) and drug-eluting stents (DES) are still controversial. The objective was to compare safety and efficacy between DES...

... intravascular ultrasound study showed that drug-eluting stents may have a different effect on reducing IH accumulation in lesions with preinterventional positive remodeling characteristics which may be related to the different properties of the drug and delivery platform. 11 01 2010 26 03 2010 30...

... not yet been fully elucidated in patients with diabetes mellitus. The purpose of this study was to evaluate whether hemoglobin A1c is associated with a risk of major adverse cardiac events (MACE) after successful drug-eluting stent (DES) implantation in patients with diabetes mellitus. Methods...

... of acetylcholine. A good correlation between the changes in blood flow during intravascular acetylcholine infusion and cold pressor testing (CPT) has supported the use of CPT as a noninvasive method to study coronary endothelial function [ 8 ]. Drug-eluting stents are considered to be a breakthrough...

...K. Tiroch; W. Koch; J. Mehilli; C. Böttiger; A. Schömig; A. Kastrati Objective: Drug-eluting stents (DES) have reduced restenosis rates compared with bare-metal stents. P27 and P53 play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis...